Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | TYMP | P19971 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N4-Hydroxycytosine SCHEMBL13071713 | 0.72 | — | — | |
| N4-Hydroxycytosine SCHEMBL24574318 | 0.72 | — | — | |
| SCHEMBL10654025 | 0.70 | NQO2 (0.40) | CRBNMMP2 | |
| SCHEMBL10653826 | 0.68 | CRBN (0.41) | CRBNMMP2 | |
| SCHEMBL10652272 | 0.67 | MEN1 (0.41) | CRBNMMP2 | |
| SCHEMBL10653786 | 0.66 | PTGS2 (0.42) | CRBNMMP2 | |
| SCHEMBL10656570 | 0.64 | CRBN (0.41) | CRBNMMP2 | |
| SCHEMBL10655874 | 0.64 | CRBN (0.41) | CRBNMMP2 | |
| Uracil SCHEMBL11607890 | 0.63 | — | — | |
| Uracil SCHEMBL5089507 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2094863-B1 | PEPTIDE NUCLEIC ACID OLIGOMERS COMPRISING UNIVERSAL BASES, PREPARATION METHODS THEREOF, AND KITS, DEVICES AND METHODS FOR THE ANALYSIS, DETECTION OR MODULATION OF NUCLEIC ACIDS USING THE SAME | PANAGENE INC (KR) | 2014-08-06 | — | — | EP | disclosed |
| US-20100292471-A1 | PEPTIDE NUCLEIC ACID OLIGOMERS COMPRISING UNIVERSAL BASES,PREPARATION METHODS THEREOF, AND KITS, DEVICES AND METHODS FOR THE ANALYSIS, DETECTION OR MODULATION OF NUCLEIC ACIDS USING THE SAME | PANAGENE INC. (KR) | 2010-11-18 | — | — | US | disclosed |
| US-20080233557-A1 | PNA Probes, Kits, and Methods for Detecting Lamivudine-Resistant Hepatitis B Viruses | PANAGENE INC. (KR) | 2008-09-25 | — | — | US | disclosed |
| US-20080233557-A1 | PNA Probes, Kits, and Methods for Detecting Lamivudine-Resistant Hepatitis B Viruses | PANAGENE INC. (KR) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080233557-A1 | PNA Probes, Kits, and Methods for Detecting Lamivudine-Resistant Hepatitis B Viruses | POLM, RNPEP, PNP | CRBN 3279/4885MMP2 1950/4885TYMP 5/4885 |
| US-20100292471-A1 | PEPTIDE NUCLEIC ACID OLIGOMERS COMPRISING UNIVERSAL BASES,PREPARATION METHODS THEREOF, AND KITS, DEVICES AND METHODS FOR THE ANALYSIS, DETECTION OR MODULATION OF NUCLEIC ACIDS USING THE SAME | ADAR, POLM, POLRMT | CRBN 3365/4885MMP2 2705/4885TYMP 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.